
Context Therapeutics Reports Q1 2025 Financial Results and Clinical Progress
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced financial results for the first quarter ended March 31, 2025, alongside updates on its clinical pipeline and leadership. The company …
Context Therapeutics Reports Q1 2025 Financial Results and Clinical Progress Read More